2010ESMO臨床實(shí)踐指南：小細(xì)胞肺癌
《2010ESMO臨床實(shí)踐指南：小細(xì)胞肺癌》內(nèi)容預(yù)覽
incidence
The most common cause of cancer-related deaths in Europe in2006 is lung cancer (estimated 334 800 deaths). After prostatecancer, lung cancer is the most frequent type of cancer in men.
Age-standardized incidence and mortality rates in 2006 areestimated to be 75.3 and 64.8/100 000/year, respectively, inmen, and 18.3 and 15.1/100 000/year in women. Small-cell lungcancer (SCLC) accounts for 15%–18% of all cases. In recentyears the incidence of SCLC has decreased. SCLC is stronglyassociated with tobacco smoking.
diagnosis
Pathological diagnosis should be made according to the WHOclassification. Biopsies can be obtained by flexiblebronchoscopy, mediastinoscopy, endoscopic ultrasound,transthoracic needle aspiration and thoracoscopy depending onthe localization of the tumour. A biopsy from a metastaticlesion can substitute for a biopsy from the primary tumour.The least invasive approach should be used [V, D].
staging and risk assessmentStaging procedures should include medical history, physicalexamination, chest X-ray, complete blood count includingdifferential count, liver, lung and renal function tests, lactatedehydrogenase (LDH) and sodium levels, and a CT scan of thechest and abdomen including the liver and adrenal glands.In patients with symptoms or abnormal physical
點(diǎn)擊下載***：《2010ESMO臨床實(shí)踐指南：小細(xì)胞肺癌》
本站所注明來源為"愛愛醫(yī)"的文章，版權(quán)歸作者與本站共同所有，非經(jīng)授權(quán)不得轉(zhuǎn)載。
本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的，且明確注明來源和作者，不希望被轉(zhuǎn)載的媒體或個(gè)人可與我們
聯(lián)系z(mì)lzs@120.net，我們將立即進(jìn)行刪除處理
